"Non alcoholic fatty liver disease and eNOS dysfunction in humans".

Marcello PersicoMario MasaroneAntonio DamatoMariateresa AmbrosioAlessandro FedericoValerio RosatoTommaso BucciAlbino CarrizzoCarmine Vecchione

Published in: BMC gastroenterology (2017)

Our data showed, for the first time in humans, that NAFLD patients show a marked eNOS dysfunction, which may contribute to a higher CV risk. eNOS dysfunction observed in platelets and liver tissue didn't match with FMD.

Keyphrases

nitric oxide synthase
end stage renal disease
pi k akt
endothelial cells
oxidative stress
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
electronic health record
signaling pathway
patient reported outcomes
deep learning